Ignite Creation Date:
2024-05-05 @ 9:28 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00891124
Status:
COMPLETED
Last Update Posted:
2009-11-03
First Post:
2009-04-28
Brief Title:
Effect of PATient Education Related to CV Risk factOrs in Type 2 Diabetes MellitusPatrol
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Multi-center Prospective Observational Study to Assess the Effect of Patient Education Related to CV Risk Factors in Type 2 Diabetes Mellitus
Status:
COMPLETED
Status Verified Date:
2009-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PATROL
Brief Summary:
This study will address the proportion of achievement patients in treatment target goal on glycemic control hypertension and hyperlipidemia according to ADA 2008 guideline among outpatients coming to the Korean primary care nationwide
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None